New York's Retail Worker Safety Act takes effect
The law requires retail employers in New York to provide workplace violence prevention training, provide employees with silent alarm buttons to contact security, and establish a written workplace violence prevention policy.
Originally, the law would have given retail workers panic buttons that would call 911. Governor Hochul then signed an amendment to the law, saying the buttons now request immediate assistance from security or management.
Other changes to the law include templates of the policy to be provided in twelve of the most common non-English languages spoken in New York instead of how many of people in the state's population who speak each language. Employers with fewer than 50 employees must provide training upon hire and once every two years.
The full amendment and law can be read by clicking here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
42 minutes ago
- Business Wire
OnMed Named Among Top 7% of Fastest-Growing Companies in America
NEW YORK--(BUSINESS WIRE)--Inc., the leading media brand and playbook for entrepreneurs, announced today that OnMed is No. 337 in the annual Inc. 5000 list, placing the company in the top 7% of the fastest-growing private companies in America. As the demand for access to healthcare continues to exponentially grow, this honor recognizes OnMed as a fast-growing alternative to clinic-based care and telemedicine, which have both hit a ceiling from a sustainability standpoint. 'An incredible purpose, a high-performing team that's in it together, and laser-focused execution can move mountains,' said Karthik Ganesh, CEO of OnMed. 'We're grateful to be on this list but we're only getting started.' Share 'An incredible purpose, a high-performing team that's in it together, and laser-focused execution can move mountains,' said Karthik Ganesh, CEO of OnMed. 'We're grateful to be on this list but we're only getting started.' From its roots as a bold idea to reimagine healthcare delivery, OnMed now operates in seven states, with plans to play a central role in the healthcare solution envisioned by the One Big Beautiful Bill (OBBB). The company's patented CareStation, an 8' x 11' Clinic-in-a-Box combines the scalability of telehealth with the human approach and diagnostics of a clinic. Serving primary, urgent, and post-acute care in one secure, tech-enabled space, this is a new model for our public health infrastructure that delivers convenience, affordability, and a personal care experience. In a healthcare landscape often dominated by tech-for-tech's sake, wearables, and AI tools that fail to reach millions of underserved Americans, OnMed stands apart. Its vision is clear: everyday healthcare, everywhere. OnMed's purpose is singular, but powerful, to improve the quality of life and sense of wellbeing in communities by bringing timely care, where and when it is needed most. By partnering with public and private organizations; including payors, health systems, colleges, government agencies, and employers; and being deployed at places like grocery stores, homeless shelters, airports, prisons, and community centers; OnMed is bringing care to meet people seamlessly in their lives. 'This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market,' said Mike Hofman, editor-in-chief of Inc. 'They didn't just weather the storm—they grew through it.' For the full list of Inc. 5000 companies, visit: Inc. will celebrate the honorees at the 2025 Inc. 5000 Conference & Gala, taking place October 22–24 in Phoenix. About OnMed OnMed is the premier tech-enabled hybrid care company partnering with public and private organizations to reimagine healthcare access and improve health equity in communities across the country. With its patented 8' x 11' CareStations, OnMed combines the best elements of traditional primary, urgent, and post-acute care with the technology of telemedicine to deliver convenient, affordable care to underserved communities, anywhere they are. The company licenses its cutting-edge technology and care delivery model to a wide range of organizations, including governments, employers, colleges, healthcare provider systems, payors, and high- traffic venues. OnMed is paving the way for everyday healthcare, everywhere.
Business Wire
42 minutes ago
- Business Wire
Coverys Report Reveals Diagnostic Errors Occur Most Frequently in Office-Based Care
BOSTON--(BUSINESS WIRE)-- Coverys, a leading provider of medical professional liability (MPL) insurance and healthcare risk management services, today released the second report in a three-part series, A Dose of Insight – Hidden in Plain Sight: Exposing the Drivers of Diagnostic Error, Part Two: Office-Based Practice. Drawing on an in-depth analysis of Coverys medical malpractice claims from 2020 to 2024, the report highlights the ongoing and often underestimated threat of diagnostic errors in office-based practices. It brings attention to critical patterns—such as the frequent occurrence of missed cancer diagnoses—and underscores the need for greater awareness and system-level improvements to support more accurate and timely diagnoses. The report's key findings include: Key Findings: 27% of malpractice events closed during the five-year period studied involved diagnostic error. Diagnostic error occurs most frequently in office-based settings, accounting for 34% of diagnosis-related events. 45% of office-based events alleged a missed cancer diagnosis. The most common missed cancers were prostate, lung, breast, and colorectal. One-third of office-based diagnostic error events resulted in a patient's death, and 22% resulted in a patient suffering a high-severity injury. Together, these tragic events accounted for 72% of the indemnity paid. 'Improving diagnostic accuracy is one of the most meaningful ways we can enhance patient safety,' said Dana Siegal, RN, CPHRM, CPPS, Vice President, Risk Management and Analytics at Coverys. "Unlike office-based procedures which are generally less urgent and complex than those performed in surgical or labor and delivery settings, diagnostic errors—particularly in outpatient settings—pose an underestimated threat to the safety and quality of patient care. This report provides data-informed actionable guidance to help clinicians recognize and address these risks, ultimately aiming to minimize patient harm." Understanding and addressing the key vulnerabilities and commonly missed diagnoses identified in this report can significantly reduce diagnostic errors in the office setting. While the data highlights serious challenges, the empirical analysis also offers insights into five practical actions providers can take to enhance diagnostic accuracy and eliminate the hidden drivers of diagnostic errors in office-based care. The report is the second installment in a three-part series examining diagnostic challenges in three care settings. The series began with an in-depth analysis of emergency departments, where diagnostic accuracy is often compromised by high patient volumes and time-sensitive decision-making. A future report will examine inpatient care and the unique diagnostic risks faced by hospitalized patients and their clinical teams. In alignment with this important work, the Coverys Community Healthcare Foundation, Inc. (CCHF) is pleased to announce a new grant opportunity focused on reducing diagnostic error and enhancing patient outcomes. Grants will support innovative programs in the following settings: Emergency Department, Office-Based Practice, and Hospital Inpatient Care. For more information and to apply, visit the CCHF Grant Page. The Dose of Insight report was co-authored by Dana Siegal, RN, CPHRM, CPPS, Vice President, Risk Management & Analytics; Maryann Small, MBA, Senior Director, Business Analytics; Susan L. Montminy, EdD, MPA, BSN, RN, FASHRM, CPHRM, CPPS, Senior Director, Risk Management & Analytics; Marlene Icenhower, BSN, JD, CPHRM, Senior Risk Specialist, Risk Management & Analytics; Patricia Bennett, RN, CPC, Senior Manager Clinical Coding, Business Analytics; Michelle Bondurant, RN, CP, Clinical Data Manager, Business Analytics. The full report is available at About Coverys With close to $4 billion in assets and 50 years of protecting healthcare, Coverys is a leading provider of medical professional liability insurance. Coverys offers a full range of healthcare liability insurance options, complemented by advanced data analytics, evidence-based processes, and best-in-class risk management and education resources. With Coverys, healthcare providers can confidently focus on improving clinical, operational, and financial outcomes. For more information, visit
Forbes
an hour ago
- Forbes
Small Investment, Big Returns: Why This NIH Center Matters
UNITED STATES - MAY 10: Activists hold signs during rally outside the National Institutes of Health in Bethesda, Md., on Saturday, May 10, 2025. (Bill Clark/CQ-Roll Call, Inc via Getty Images) CQ-Roll Call, Inc via Getty Images 25 years ago, I had a life-changing experience. I got the biggest break in my career. My application to do a PhD at the University of California, Berkeley was accepted, and I was offered funding support through a National Institutes of Health (NIH) program called the Fogarty AIDS International Training Program. I had little money those days, and without NIH funding and a welcoming professor who cared deeply about global health, I could have never left India for higher education in the United States. Today, I chair a department of global and public health at a leading Canadian university. The life-changing opportunities I had as a Fogarty trainee at Berkeley allow me to pay it forward by training the next generation of global health leaders. I was not the only scholar to benefit from Fogarty funding - nearly 8,500 individuals from 132 countries have trained through Fogarty programs since 1989, and many have become leaders in their countries. Several have led groudbreaking research projects, and led inspiring programs and institutions. Soumya Swaminathan is a great example. After her Fogarty training in the United States, she went on to become a leading HIV and TB researcher, become the Director-General of the Indian Council of Medical Research, and subsequently the first Chief Scientist of the World Health Organization. 'My Fogarty fellowship gave me an opportunity to get exposed to advanced immunological techniques and meet leading experts at a critical stage of my career. It helped spark new ideas and initiate collaboration with international experts which may not have happened otherwise,' she said. Another shining example is Glenda Gray, who was the first female President of the South African Medical Research Council. 'Becoming a Fogarty Fellow catalysed my career as a clinician scientist, and marked the beginning of my research trajectory," she said. "It enabled me to make contributions to HIV vaccine research and development, as well as research in the area of preventing mother to child transmission. The interventions we developed have led to the control of paediatric HIV and improvements in treatment that have reduced HIV-related mortality in children,' she explained. Gray is currently Director of the Infectious Disease and Oncology Research Institute, University of the Witwatersrand. The Fogarty International Center (FIC) has also benefitted US scientists and institutions. In FY24, Fogarty funded 440 U.S. grantees from 122 U.S. institutions in 39 states. Research conducted in Global South countries have led to improved treatments for health challenges of importance to Americans. 'The training programs supported by the FIC over the past 40 years have been unparalleled in their reach and impact around the world,' said Arthur Reingold, Emeritus professor at Berkeley School of Public Health, who has trained hundreds of scholars through his Fogarty grants. 'They have, through their support of highly talented biomedical scientists from scores of low and middle income countries, dramatically improved research and educational capacity globally, as well as markedly enhanced high impact collaborative research on AIDS, tuberculosis, malaria, and diverse other communicable and non communicable diseases. The benefits resulting from the enhanced research capabilities of scientists supported by the FIC have accrued to people living everywhere, including in the United States,' he elaborated. Lucian Davis, an Associate Professor at Yale Medicine and the Yale School of Public Health, has also used the Fogarty program to train dozens of American and African scholars. 'Fogarty enables us to train the world's brightest minds to tackle America's leading health priorities—a high-impact, low-cost investment that keeps us connected to the world,' he said. And guess what, the entire annual budget of the FIC is a merely 0.2% of the total NIH budget - a drop in the bucket. Despite this tiny investment, the FIC has had a spectacular national and global footprint and impact, by any metric. Today, it greatly saddens me to see defunding of US science agencies, including NIH, and it's devastating impact on US academic institutions and scientists. Several American scientists have either reached out to me to explore options in Canada, or have applied for faculty positions at my university. Scores of American scientists are seeking to flee the country (and become "science refugees"). It boggles my mind that US politicians are allowing this brain drain to happen under their watch. America's economic strength, in part, comes from the nation's immense scientific firepower. I am especially distressed to learn that the FIC is once again on the chopping block, with the entire $95 million budget FIC budget set to become zero in 2026. How exactly is cutting such an impactful program supposed to make America great? Even as the world deals with massive crises like pandemics, conflicts, climate change, and widening economic inequities, all of which require truly, global cooperation and coordination, it seems like politicians are choosing narrow self-interests, nationalism, and isolationism. This strategy is not likely to succeed. Why? We've all witnessed how interconnected the world is during the Covid-19 pandemic. Viruses that emerge in far away places will find us, regardless of who we are or where we happen to live. Every outbreak is merely one long-haul flight away. Smoke from wildfires will travel thousands of miles to darken our skies and choke our lungs. NEW YORK, NEW YORK - JUNE 7: Smoky haze from wildfires in Canada diminishes the visibility of the Chrysler Building on June 7, 2023 in New York City. (Photo by David) Getty Images There is no way to protect just one nation or one region when threats are trans-national. Our fates are undisputably intertwined with that of other countries and peoples. There is nothing 'woke' about looking out for each other in an interdependent world. And that is why America must stay engaged in global health and multi-laterialism. And that is why American lawmakers must work to protect a national treasure like the Fogarty International Center. If an investment is yielding spectacular returns, no smart business person would dream of killing it. So, why defund the FIC and the NIH? If I was a US lawmaker, that is the question I would be asking myself. I take some hope from the fact that the Senate Appropriations Committee recently rejected the Trump administration's proposed funding cuts to the NIH. But the road ahead is long and hard. I hope good sense will prevail and the powers that be will find a way to save America's phenomenal scientific enterprise. Science matters for America's health. It matters for health of the whole world.
